Sana Biotechnology, Inc. |
10%+ Owner |
Common Stock |
11.4M |
$45.8M |
$4.00 |
Jun 6, 2023 |
By Flagship VentureLabs V, LLC |
Sana Biotechnology, Inc. |
10%+ Owner |
Common Stock |
10.7M |
$43M |
$4.00 |
Jun 7, 2023 |
By Flagship Ventures Fund V, L.P. |
Sana Biotechnology, Inc. |
10%+ Owner |
Common Stock |
9.73M |
$38.9M |
$4.00 |
Jun 6, 2023 |
By Flagship Pioneering Fund VI, L.P. |
Sana Biotechnology, Inc. |
10%+ Owner |
Common Stock |
1.38M |
$5.52M |
$4.00 |
Jun 7, 2023 |
By Flagship V VentureLabs Rx Fund, L.P. |
Codiak BioSciences, Inc. |
10%+ Owner |
Common Stock |
1.87M |
|
|
Sep 15, 2022 |
By Flagship Ventures Fund V, L.P. |
Codiak BioSciences, Inc. |
10%+ Owner |
Common Stock |
1.19M |
|
|
Sep 15, 2022 |
By Flagship V VentureLabs Rx Fund, L.P. |
Codiak BioSciences, Inc. |
10%+ Owner |
Warrants to purchase Common Stock |
723K |
|
|
Sep 15, 2022 |
By Flagship Ventures Fund V, L.P. |
Codiak BioSciences, Inc. |
10%+ Owner |
Common Stock |
486K |
|
|
Sep 15, 2022 |
Flagship VentureLabs V LLC |
Codiak BioSciences, Inc. |
10%+ Owner |
Warrants to purchase Common Stock |
211K |
|
|
Sep 15, 2022 |
By Flagship V VentureLabs Rx Fund, L.P. |
Sigilon Therapeutics, Inc. |
10%+ Owner |
Common Stock |
0 |
|
|
Aug 11, 2023 |
By Flagship Pioneering Special Opportunities Fund II, L.P. |
Sigilon Therapeutics, Inc. |
10%+ Owner |
Common Stock |
0 |
|
|
Aug 11, 2023 |
By Flagship Ventures Fund V, L.P. |